Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,069 | -77,487 | -57,913 | -38,534 | -16,882 |
| Depreciation Amortization | 2,751 | 9,529 | 7,091 | 4,667 | 2,297 |
| Accounts receivable | 469 | -6,603 | 31 | -1,298 | -2,961 |
| Accounts payable and accrued liabilities | -3,275 | 16,930 | 3,678 | 2,815 | 813 |
| Other Working Capital | -3,484 | 10,507 | 5,604 | 2,813 | -783 |
| Other Operating Activity | 7,488 | 11,231 | 13,752 | 10,573 | 6,766 |
| Operating Cash Flow | $-15,120 | $-35,893 | $-27,757 | $-18,964 | $-10,750 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -493 | N/A | N/A |
| PPE Investments | -878 | -574 | -236 | -130 | N/A |
| Purchase Of Investment | N/A | -1,885 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -32 | -108 | -223 | -87 | -46 |
| Other Investing Activity | -1,703 | -6,211 | -4,438 | -2,461 | -1,039 |
| Investing Cash Flow | $-2,581 | $-8,670 | $-5,167 | $-2,591 | $-1,039 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 34,563 | 34,563 | 34,563 | N/A |
| Common Stock Issued | 14,959 | 1,439 | 199 | 115 | 40 |
| Other Financing Activity | -1,917 | -5,825 | -4,200 | -2,129 | -1,030 |
| Financing Cash Flow | $13,042 | $30,177 | $30,562 | $32,549 | $-990 |
| Exchange Rate Effect | -238 | 4,449 | 3,746 | 3,602 | 1,081 |
| Beginning Cash Position | 70,289 | 80,226 | 80,226 | 80,226 | 80,226 |
| End Cash Position | 65,392 | 70,289 | 81,610 | 94,822 | 68,528 |
| Net Cash Flow | $-4,897 | $-9,937 | $1,384 | $14,596 | $-11,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,120 | -35,893 | -27,757 | -18,964 | -10,750 |
| Capital Expenditure | -878 | -574 | -236 | -130 | N/A |
| Free Cash Flow | -15,998 | -36,467 | -27,993 | -19,094 | -10,750 |